How to manage GLP-1s in the hospital
Today's Hospitalist
JUNE 7, 2025
“You want someone who can monitor patients’ side effects and have a longitudinal relationship with them.” That research found that the drug reduced the combined risk of worsening heart failure events and cardiovascular death in a population with obesity and preexisting cardiovascular disease.
Let's personalize your content